About DAKLAK PHARMACEUTICAL MEDICA
ISIN
VN000000DBM1
FIGI
BBG000Q08K70
Manufactures pharmaceutical products and buys & sells pharmaceuticals, chemicals, medical, dental, optical and hospital equipment
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DBM is 24100 VND — it has decreased by 4.37% in the past 24 hours. Watch DAKLAK PHARMACEUTICAL MEDICA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on UPCOM exchange DAKLAK PHARMACEUTICAL MEDICA stocks are traded under the ticker DBM.
DBM stock has fallen by 17.75% compared to the previous week, the month change is a 5.49% fall, over the last year DAKLAK PHARMACEUTICAL MEDICA has showed a 32.11% decrease.
No, DBM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DBM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DAKLAK PHARMACEUTICAL MEDICA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DAKLAK PHARMACEUTICAL MEDICA technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DAKLAK PHARMACEUTICAL MEDICA stock shows the strong sell signal. See more of DAKLAK PHARMACEUTICAL MEDICA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.